PharmaCorp Rx Inc.
PCRX.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -310.40K | -286.50K | 177.20K | 542.40K | -714.10K |
| Total Depreciation and Amortization | 161.40K | 136.30K | 130.60K | 136.80K | 55.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 142.30K | -7.00K | -14.10K | -426.70K | 537.50K |
| Change in Net Operating Assets | 406.10K | 22.10K | -203.40K | 543.70K | -350.40K |
| Cash from Operations | 399.50K | -135.00K | 90.30K | 796.20K | -471.40K |
| Capital Expenditure | 1.51M | -1.53M | -18.70K | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -7.44M | -736.50K | -- | -10.61M | -1.53M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -5.93M | -2.27M | -18.70K | -10.61M | -1.53M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -61.00K | -50.50K | -50.70K | -51.10K | -40.70K |
| Issuance of Common Stock | 3.16M | -- | -- | 0.00 | 7.64M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -18.20K | -- | -- | -- | -- |
| Cash from Financing | 2.24M | -36.50K | -35.30K | -36.50K | 5.57M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.30M | -2.44M | 36.20K | -9.85M | 3.57M |